Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unprecedented response to combination BRAF and MEK inhibitors in adult anaplastic ganglioglioma.

× No keyword cloud information.

3 in total

Review 1. Malignant transformation and leptomeningeal spread of recurrent ganglioglioma: case report and review of literature.

Authors: Grant Riesberg; Girish Bathla; Sarika Gupta; Pankaj Watal; Toshio Moritani
Journal: Clin Imaging Date: 2017-09-20 Impact factor: 1.605

Review 2. Management of Treatment-Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma.

Authors: Adil Daud; Katy Tsai
Journal: Oncologist Date: 2017-05-18

3. Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database.

Authors: Senthil K Selvanathan; Salah Hammouche; Heidi J Salminen; Michael D Jenkinson
Journal: J Neurooncol Date: 2011-05-29 Impact factor: 4.130

3 in total

2 in total

1. Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm.

Authors: Adam Kowalewski; Justyna Durślewicz; Marek Zdrenka; Dariusz Grzanka; Łukasz Szylberg
Journal: Target Oncol Date: 2020-08 Impact factor: 4.493

Review 2. BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors.

Authors: Karisa C Schreck; Stuart A Grossman; Christine A Pratilas
Journal: Cancers (Basel) Date: 2019-08-28 Impact factor: 6.639

2 in total